Nashua medtech manufacturer hosts regional innovation gathering as New Hampshire targets life-sciences growth

Resonetics, a Nashua-based medical-device contract development and manufacturing company, hosted representatives from nearly two dozen companies on June 3 for a regional medtech gathering at its Nashua operation.

The event included a medtech panel, networking and lightning-round presentations. It brought together people working across medical-device engineering, life sciences and technology, according to NH Life Sciences, which reported on the gathering.

Resonetics specializes in nitinol and provides contract development and manufacturing services for medical devices. The event offers a documented example of companies and organizations convening around those technical and manufacturing activities in Nashua.

Focus on a state growth area

Participants discussed New Hampshire’s life-sciences sector as a priority growth area. The discussion placed medical-device development and manufacturing within a broader effort to build connections among companies and support commercialization activity in the state.

The gathering itself was a networking and information-sharing event, not an announcement of a new medical product or deployed technology. The available report does not identify all of the participating companies or describe a specific contract, investment, product launch, grant award or facility expansion resulting from the meeting.

That distinction matters in assessing the significance of the event. The reported result is collaboration: representatives from nearly two dozen companies met, participated in a panel and gave presentations. The source does not establish a measured business or health outcome from that activity.

Research funding discussed

Small Business Innovation Research, or SBIR, and Small Business Technology Transfer, or STTR, grants were identified during the discussion as important sources of research-and-development funding. Those programs were presented as funding opportunities relevant to life-sciences and technology work, rather than as grants awarded at the Nashua event.

For companies developing medical-device technologies, the discussion linked regional collaboration with potential routes to research funding. But the report does not quantify funding sought or received by participants, nor does it provide estimates of jobs or investment tied to the gathering.

As reported, the June 3 event is a snapshot of an active regional medtech network centered in part on a Nashua manufacturer. Its longer-term effects on commercialization, employment or medical-device development remain unreported in the available source.